The UK has had legal medical cannabis since 2018, yet many patients still learn that fact from a friend, a forum or an advert. That gap between policy and public understanding is where The Ganja Club begins.
We are here to cover a field that is too often split between institutional caution and commercial hype. Patients deserve something more useful: reporting that explains what changed, analysis that tests what it means and practical guidance that admits where the evidence stops.
What we cover
Our newsroom follows UK access, regulation, clinical research and the culture forming around legal treatment. We examine the decisions of government, regulators, clinics and industry — but keep the patient experience at the centre of the story.
That means asking basic questions relentlessly. Can a patient find a credible route into care? What does it cost? Which claims are supported? Who benefits from a policy change, and who is still excluded?
How we work
We distinguish briefings from analysis, guides from reviews and editorial coverage from commercial relationships. Sources should be visible where available. Uncertainty should be stated, not smoothed away. Affiliate links and sponsored work should be labelled.
We will not treat cannabis as a miracle cure, and we will not treat decades of stigma as a substitute for evidence. Both shortcuts fail readers.
Why culture belongs here
Medicine does not exist outside culture. Patients navigate family conversations, workplaces, driving rules and healthcare systems that may still misunderstand their prescriptions. Language, design, community and stigma all influence whether legal treatment feels legitimate.
Covering that reality is not a diversion from medical reporting. It is part of explaining how policy operates in people's lives.
The Ganja Club is a publication for readers who want the full picture: progress without boosterism, scrutiny without reflexive hostility and a clear view of the system nobody properly explains. Welcome in.
